Valeant Pharmaceuticals International Valeant tells top Allergan shareholders that it might consider splitting itself up if it got too large to continue pursuing its acquisition strategy - press
- The comments were in response to some analysts who suggested Valeant's proposed combination with Allergan would make it too large to find new acquisition targets that could add meaningfully to its growth.